Disease management
Also, SeekIn is set to release an AI-based all-cancer screening test in Europe.
The feature uses a smartphone camera and flash to calculate a user's heart rate.
Also: Rupa Health raised $20 million for its lab test platform, and CancerIQ scooped up $14 million in Series B funding.
The agreement also allows the companies to develop new or improved tools for Dario's chronic condition management platform.
The non-prick device can measure blood glucose and monitor blood pressure without pressure cuffs.
Motion Trainer uses computer vision to provide feedback to users.
The virtual care giant said the latest offering was accelerated by its merger with Livongo in 2020.
It gauges a user's bodily readiness to engage in a certain physical activity.
The company's REMI product is currently FDA cleared for in-hospital use, but Epitel plans to expand into ambulatory and in-home care.
MFine users can now book tests from Datar Cancer Genetics.